IFNA13 anticorps (C-Term)
Aperçu rapide pour IFNA13 anticorps (C-Term) (ABIN926586)
Antigène
Voir toutes IFNA13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified
-
Immunogène
- IFNA13 antibody was raised in rabbit using the C terminal of IFNA13 as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
IFNA13 Blocking Peptide, (ABIN939424), is also available for use as a blocking control in assays to test for specificity of this IFNA13 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- IFNA13 (Interferon, alpha 13 (IFNA13))
-
Autre désignation
- IFNA13
-
Sujet
- IFNA13 is produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. Synonyms: Polyclonal IFNA13 antibody, Anti-IFNA13 antibody, interferon, alpha 13 antibody, IFNA1 antibody.
-
Pathways
- Signalistation JAK/STAT, Hepatitis C
Antigène
-